Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0747 per EA under NDC 00781569031. Its NADAC has been published 395 times since Aug 9, 2017.
The High Outlier badge above means this manufacturer's average price in the Ezetimibe market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Sandoz Inc.NDC
00781569031
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/19/2025
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA203931On Market Since
6/12/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 395 times since Aug 9, 2017, and over the history we have for it it has declined 98.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0747 per EA |
|---|---|
| All-time high | $6.9413 (Aug 16, 2017) |
| All-time low | $0.0718 (May 22, 2024) |
| Median price | $0.1542 |
| Average price | $0.2355 |
| Largest weekly change | -88.2% (Sep 20, 2017) |
| Weeks tracked | 395 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 13 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Sandoz Inc., is $0.0747 per EA (NDC 00781569031), effective Feb 26, 2025.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 98.9%. It has been tracked across 395 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Aug 9, 2017, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0718 (May 22, 2024) to a high of $6.9413 (Aug 16, 2017), with a median of $0.1542 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
Yes. 13 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0691 per EA — about 7% below EZETIMIBE 10 MG TABLET.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 00781569031) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification